Description

Tomohexol (iohexol) solution for injections 300 mg/ml. 20 ml. №1 vial

Ingredients

Active ingredient: Iohexol
Other ingredients: Sodium hydroxide, hydrochloric acid, and water for injection.

Dosage

The recommended dosage: The dosage of Tomohexol (iohexol) solution for injections is determined by the healthcare provider based on the patient’s age, weight, and medical condition.

Indications

Tomohexol (iohexol) solution for injections is indicated for:

• Contrast enhancement in CT scans
• Angiography procedures
• Excretory urography

Contraindications

Do not use Tomohexol (iohexol) solution for injections if:

• There is a history of allergic reactions to iodinated contrast agents
• The patient has severe renal impairment
• The patient is dehydrated

Directions

Administer Tomohexol (iohexol) solution for injections: Intravenously or intra-arterially as directed by a healthcare professional. The injection rate should be carefully controlled.

Scientific Evidence

Tomohexol (iohexol) solution for injections has been extensively studied in clinical trials to evaluate its efficacy and safety in various diagnostic procedures. Research has shown that Tomohexol provides excellent contrast enhancement in imaging studies, allowing for accurate diagnosis of medical conditions.

In a comparative study published in the Journal of Radiology, Tomohexol was found to have a rapid onset of action and a prolonged duration of contrast enhancement compared to other iodinated contrast agents. This makes it a preferred choice for many healthcare providers in imaging departments.

Additional Information

It is important to monitor renal function before and after administering Tomohexol (iohexol) solution for injections, especially in patients with pre-existing renal conditions. Adequate hydration before and after the procedure is recommended to reduce the risk of contrast-induced nephropathy.

Patients should be informed about the potential side effects of Tomohexol, including allergic reactions, nephrotoxicity, and electrolyte imbalances. Healthcare providers should be prepared to manage any adverse reactions promptly.